ClinicalTrialsFinder

Primary Resistance Clinical Trials in Changsha, Hunan

1 recruitingChangsha, Hunan, China

Showing 1–1 of 1 trials

Recruiting

Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

Lung Cancer (Non-Small Cell)Circulating Tumor DNAEGFR-TKI Resistant Mutation+2 more
Second Xiangya Hospital of Central South University210 enrolled1 locationNCT05598528